First Patient Enrolled in DUBSTENT Diabetes PCI Trial
September 11, 2025
Teleflex Incorporated, a leading global provider of medical technologies, announced the enrollment of the first patient in the DUBSTENT DIABETES trial. The randomized, investigator-initiated clinical